JW Pharmaceutical Corp (KO:001065) — Market Cap & Net Worth
Market Cap & Net Worth: JW Pharmaceutical Corp (001065)
JW Pharmaceutical Corp (KO:001065) has a market capitalization of $279.87 Million (₩412.97 Billion) as of June 19, 2026. Listed on the KO stock exchange, this Korea-based company holds position #15260 globally and #519 in its home market, demonstrating a -3.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JW Pharmaceutical Corp's stock price ₩20550.00 by its total outstanding shares 20096000 (20.10 Million). Review 001065 liabilities breakdown to assess the company's total debt and financial obligations.
JW Pharmaceutical Corp Market Cap History: 2015 to 2026
JW Pharmaceutical Corp's market capitalization history from 2015 to 2026. Data shows growth from $265.07 Million to $279.87 Million (1.04% CAGR).
JW Pharmaceutical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JW Pharmaceutical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
JW Pharmaceutical Corp's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
JW Pharmaceutical Corp's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $265.07 Million | $434.35 Billion | $1.96 Billion | 0.00x | 0.14x |
| 2016 | $267.59 Million | $467.47 Billion | -$10.93 Billion | 0.00x | N/A |
| 2017 | $284.04 Million | $502.92 Billion | -$742.47 Million | 0.00x | N/A |
| 2018 | $286.76 Million | $537.18 Billion | $8.06 Billion | 0.00x | 0.04x |
| 2019 | $327.70 Million | $511.34 Billion | -$25.28 Billion | 0.00x | N/A |
| 2020 | $496.85 Million | $547.34 Billion | -$15.24 Billion | 0.00x | N/A |
| 2021 | $435.33 Million | $606.58 Billion | -$967.85 Million | 0.00x | N/A |
| 2022 | $419.35 Million | $684.35 Billion | $31.89 Billion | 0.00x | 0.01x |
| 2023 | $452.14 Million | $748.53 Billion | $37.01 Billion | 0.00x | 0.01x |
| 2024 | $403.80 Million | $719.38 Billion | $65.04 Billion | 0.00x | 0.01x |
Competitor Companies of 001065 by Market Capitalization
Companies near JW Pharmaceutical Corp in the global market cap rankings as of June 19, 2026.
Key companies related to JW Pharmaceutical Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #555 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #601 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
JW Pharmaceutical Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, JW Pharmaceutical Corp's market cap moved from $265.07 Million to $ 279.87 Million, with a yearly change of 1.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩279.87 Million | -30.10% |
| 2025 | ₩400.39 Million | -0.84% |
| 2024 | ₩403.80 Million | -10.69% |
| 2023 | ₩452.14 Million | +7.82% |
| 2022 | ₩419.35 Million | -3.67% |
| 2021 | ₩435.33 Million | -12.38% |
| 2020 | ₩496.85 Million | +51.62% |
| 2019 | ₩327.70 Million | +14.28% |
| 2018 | ₩286.76 Million | +0.96% |
| 2017 | ₩284.04 Million | +6.15% |
| 2016 | ₩267.59 Million | +0.95% |
| 2015 | ₩265.07 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of JW Pharmaceutical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $279.87 Million USD |
| MoneyControl | $279.87 Million USD |
| MarketWatch | $279.87 Million USD |
| marketcap.company | $279.87 Million USD |
| Reuters | $279.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About JW Pharmaceutical Corp
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam steri… Read more